image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Chemring - Defence firm expects growth from “reverse peace dividend”

August 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CHG
  • Price:
  • 322p
Much has been made about NATO unity in the face of Russian warmongering in the Ukraine but when it comes to who wears the financial trousers there’s no doubt that the USA dominates military spending. President Biden signed off on a US$22 billion increase in Department of Defence spending for 2022 to a record US$813 billion, more than the next nine largest countries (China, India UK, Russia, France, Germany, Japan and Saudi Arabia), which are spending a combined US$777 billion. Clearly, the need to replenish stockpiles and upgrade weapons systems has never been more urgent since 1945 and the share prices of many UK defence firms including BAE Systems and Qinetiq, 380p, have outperformed the market in recent months. Another defence company ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X